DMPHF(DMPHF)
DMPHF
OTC • Last print unknown ago
$47.69—Stale · unknown old
No analyst ratings available
No analyst price targets available for DMPHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.22B | $1.27B | $1.32B | $1.37B |
| Low | $1.21B | $1.26B | $1.31B | $1.36B |
| High | $1.25B | $1.29B | $1.34B | $1.40B |
| EBITDA Avg | $356M | $382M | $398M | $407M |
| Low | $353M | $379M | $395M | $403M |
| High | $361M | $388M | $405M | $414M |
| EBIT Avg | $272M | $304M | $325M | $337M |
| Low | $269M | $301M | $322M | $333M |
| High | $277M | $310M | $332M | $344M |
| Net Income Avg | $143M | $164M | $178M | $186M |
| Low | $141M | $162M | $176M | $184M |
| High | $147M | $169M | $183M | $191M |
| EPS Avg | $2.66 | $3.06 | $3.31 | $3.46 |
| Low | $2.63 | $3.02 | $3.27 | $3.41 |
| High | $2.73 | $3.13 | $3.40 | $3.55 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 2 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $310M | $310M |
| Low | $310M | $310M |
| High | $310M | $310M |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |